PhaseWell Research Acquires Chase Medical Research to Expand Clinical Trial Capabilities in Connecticut
PhaseWell Research (“PhaseWell”), a multisite clinical research company, today announced the strategic acquisition of Chase Medical Research (“CMR”). Under the leadership of founder, key opinion leader, and lead Principal Investigator Dr. Joseph Soufer, CMR operates sites in Waterbury and Hamden, Connecticut. The partnership supports PhaseWell’s mission of connecting communities to clinical trials, bringing hope today and shaping tomorrow’s medicine.
Bio Behavioral Health Joins PhaseWell Research to Expand Access to Neuropsychiatric Clinical Trials
PhaseWell Research (“PhaseWell”), a national clinical research site company, today announced a new partnership with Bio Behavioral Health (“BBH”), a leading central nervous system (CNS) research site focused in neurologic and psychiatric disorders. The partnership reflects PhaseWell’s continued commitment to connecting communities to clinical trials, bringing hope today and shaping tomorrow’s medicine.
